Analyst Moves: THOR, MDVN
- Wednesday, October 3, 2012, 12:01
- Market
- Add a comment
Thoratec (THOR) was upgraded by UBS (UBS) from neutral to buy with a price target of $39, as the share price is inexpensive given the position the company has in a growth market.
http://www.forbes.com/sites/marketnewsvideo/2012/10/03/analyst-moves-thor-mdvn/
About the Author
admin123 has written 23442 stories on this site.
